New biobank aims to unlock secrets of blood disorder treatments
NCT ID NCT07227155
First seen Nov 12, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This study collects blood samples and health information from 375 people with non-cancerous blood diseases like aplastic anemia, sickle cell disease, and thalassemia who are getting a stem cell transplant or gene therapy. The goal is to create a biobank that helps researchers understand why these treatments work or fail, and find new ways to improve them. Participants will not receive a new treatment, but their samples will help future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOGLOBINOPATHIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.